CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Brain Research

• Publication date

  1994-08-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-8993(94)91624-1PMID 7812784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.

  1994cited by this paper
• Cell and tissue responses to oxidative damage.

  1993cited by this paper
• Oxidants, antioxidants, and the degenerative diseases of aging.

  1993cited by this paper
• Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity.

  1992cited by this paper
• A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender.

  1992cited by this paper
• Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

  1992cited by this paper
• Cold‐induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn‐Superoxide dismutase

  1991cited by this paper
• Gender differences in age effect on brain atrophy measured by magnetic resonance imaging.

  1991cited by this paper
• Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase.

  1991cited by this paper
• Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase.

  1990cited by this paper
• Oxidation reactions in Parkinson's disease. Discussion

  1990cited by this paper
• Oxidation reactions in Parkinson's disease.

  1990cited by this paper
• Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase.

  1990cited by this paper
• Oxidation reactions in Parkinson's disease

  1990cited by this paper
• Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

  1988cited by this paper
• Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

  1988cited by this paper
• A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.

  1988cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987cited by this paper
• Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

  1987cited by this paper
• Biological effects of the superoxide radical.

  1986cited by this paper
• Comparison of cardiovascular, hyperthermic, and toxic effects of para-methoxyamphetamine (PMA) and 3, 4-methylenedioxyamphetamine (MDA).

  1975cited by this paper
• The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

  1974cited by this paper
• Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals.

  1973cited by this paper

• Sexual effects of commonly used recreational psychostimulants in women and the female rat model.

  2024cites this paper
• Neurotoxicity of Drugs of Abuse

  2022cites this paper
• Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences

  2021cites this paper
• Longitudinal Examination of Learning and Memory in Rats Following Adolescent Exposure to 3,4-Methylenedioxymethamphetamine or 5-Methoxy-N,N-Diisopropyltryptamine

  2017cites this paper
• Aqueous root extract of Asparagus cochinchinensis (Lour.) Merr. Has antioxidant activity in D-galactose-induced aging mice

  2017cites this paper
• The neurotoxic mechanisms of amphetamine: Step by step for striatal dopamine depletion.

  2017cites this paper
• Tripping the light fantastic: Modeling the consequences of recreational use of MDMA or 5-MeO-DIPT in humans using weekend “rave” exposures in rat.

  2016cites this paper
• Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone.

  2015cites this paper
• Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.

  2014cites this paper
• Catechol-o-methyltransferase and 3,4-({+/-})-methylenedioxymethamphetamine toxicity.

  2014cites this paper
• Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona

  2014cites this paper
• Methylenedioxymethamphetamine-induced neurotoxicity: The role of hepatic enzymes cytochrome p450 2d6 and catechol-o-methyltransferase and contribution of microglia

  2013cites this paper
• Glucose-6-phosphate dehydrogenase deficiency: A possible risk factor for neurodegeneration associated with aging and amphetamine use

  2013influential citation
• Animal models of Parkinson’s disease and related disorders

  2013cites this paper
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Toxicity of amphetamines: an update

  2012cites this paper
• CD200 attenuates methamphetamine-induced microglial activation and dopamine depletion

  2012cites this paper
• Mice in ecstasy: advanced animal models in the study of MDMA.

  2010cites this paper
• Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

  2010cites this paper
• Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.

  2010cites this paper
• Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).

  2009cites this paper
• Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes

  2009cites this paper
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009influential citation
• Serotonin neurotoxins — past and present

  2009cites this paper
• Enhanced Tau Phosphorylation in the Hippocampus of Mice Treated with 3,4-Methylenedioxymethamphetamine (“Ecstasy”)

  2008influential citation
• Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

  2008influential citation
• Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?

  2007cites this paper
• Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

  2007cites this paper
• A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

  2007cites this paper
• Literature-Related Discovery (LRD)

  2007cites this paper
• Transdermal selegiline.

  2007cites this paper
• Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns

  2006influential citation
• Mechanisms of neuroprotection by estrogen

  2006cites this paper
• Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2006cites this paper
• Ecstasy: Are animal data consistent between species and can they translate to humans?

  2006cites this paper
• Animal Models of Parkinson ’ s Disease and Related Disorders

  2005cites this paper
• MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity.

  2005cites this paper
• Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin

  2005cites this paper
• MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females.

  2005cites this paper
• Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

  2004cites this paper
• Multiple molecular and neuropharmacological effects of MDMA (Ecstasy).

  2004cites this paper
• Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.

  2003cites this paper
• Neuroplasticity in the MPTP‐Lesioned Mouse and Nonhuman Primate

  2003cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage.

  2003cites this paper
• Estrogens: protective or risk factors in brain function?

  2003cites this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cites this paper
• 3,4-Methylenedioxymethamphetamine (MDMA) Abuse may Cause Oxidative Stress and Potential Free Radical Damage

  2003cites this paper
• Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging.

  2003cites this paper
• Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms.

  2003cites this paper
• Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein

  2002cites this paper
• Estrogen and neuroprotection: from clinical observations to molecular mechanisms

  2002cites this paper
• Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro

  2002cites this paper
• Dopamine and Its Modulation of Drug-Induced Neuronal Damage

  2002cites this paper
• Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.

  2002cites this paper
• The modulation of cellular susceptibility to oxidative stress: protective and destructive actions of Cu,Zn-superoxide dismutase.

  2002cites this paper
• Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex

  2002cites this paper
• Estrogens: trophic and protective factors in the adult brain.

  2001cites this paper
• Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action.

  2001cites this paper
• Involvement of free radicals in MDMA-induced neurotoxicity in mice.

  2001cites this paper
• Minireview: Neuroprotective Effects of Estrogen-New Insights into Mechanisms of Action.

  2001cites this paper
• 2‐Deoxy‐D‐Glucose Prevents and Nicotinamide Potentiates 3,4‐Methylenedioxymethamphetamine‐Induced Serotonin Neurotoxicity

  2000cites this paper
• Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.

  2000cites this paper
• Molecular Footprints of Neurotoxic Amphetamine Action

  2000cites this paper
• Direct interactions of methamphetamine with the nucleus.

  2000cites this paper
• Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation.

  2000cites this paper
• Effects of antihistamines on 3,4‐methylenedioxymethamphetamine‐induced depletion of serotonin in rats

  1999cites this paper
• 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

  1999cites this paper
• In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.

  1999cites this paper
• Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy).

  1999cites this paper
• Selective neurotoxins, chemical tools to probe the mind: The first Thirty years and beyond

  1999cites this paper
• N‐tert‐butyl‐alpha‐phenylnitrone protects against 3,4‐methylenedioxymethamphetamine‐induced depletion of serotonin in rats

  1999cites this paper
• The Use of Transgenic and Mutant Mice to Study Oxygen Free Radical Metabolism

  1999cites this paper
• Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum.

  1998cites this paper
• Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR

  1998cites this paper
• Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice.

  1998cites this paper
• Overexpression of copper/zinc superoxide dismutase: A novel cause of murine muscular dystrophy

  1998cites this paper
• Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.

  1998cites this paper
• Clomethiazole (Zendra®) in Acute Ischemic Stroke: Basic Pharmacology and Biochemistry and Clinical Efficacy

  1998cites this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cites this paper
• Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds

  1998cites this paper
• Effects of overexpression of the cytoplasmic copper‐zinc superoxide dismutase on the survival of neurons in vitro

  1998cites this paper
• Gender-linked brain injury in experimental stroke.

  1998cites this paper
• Chapter 19 – Antioxidant Enzymes: Developmental Profiles and Their Role in Metal-Induced Oxidative Stress

  1998cites this paper
• Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.

  1997cites this paper
• Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.

  1997cites this paper
• Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts.

  1997cites this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cites this paper
• 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.

  1997cites this paper
• Amphetamine induces hydroxyl radical formation in the striatum of rats.

  1997cites this paper
• A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

  1997cites this paper
• Increased Liver-Specific Catalase Activity in Transgenic Mice

  1996cites this paper
• AP‐1 DNA‐binding activation by methamphetamine involves oxidative stress

  1996cites this paper
• Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

  1996cites this paper
• Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals.

  1995cites this paper
• 3‐Nitropropionic Acid Neurotoxicity Is Attenuated in Copper/Zinc Superoxide Dismutase Transgenic Mice

  1995cites this paper
• Age‐related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain

  1995cites this paper
• Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice

  1995cites this paper
• Transgenic superoxide dismutase mice differ in opioid-induced analgesia.

  1995cites this paper
• INVOLVEMENT OF OXIDATIVE AND L‐ARGININE‐NO PATHWAYS IN THE NEUROTOXICITY OF DRUGS OF ABUSE IN VITRO

  1995cites this paper